avoids radiation exposure of the tissue used for reconstruction, and autologous flaps provide the benefit of replacing some of the breast and chest wall soft tissue exposed to radiation.
In recent years, implant reconstruction rates in the United States have risen in the irradiated patient population. Using the Surveillance, Epidemiology and End Results database, Agarwal and colleagues evaluated immediate reconstruction trends among irradiated patients and found a steady increase in implant-only reconstruction, from 27 percent to 52 percent, with a concomitant decrease in autologous reconstruction, from 56 percent to 32 percent, over the past decade. 9 There are concerns about the outcomes of implant reconstructions in patients who have a history of irradiation or require postmastectomy radiation therapy. A systematic review of the literature on the morbidity associated with implant reconstruction before or after radiation exposure found a pooled reconstruction failure rate of approximately 20 percent. In addition, other studies have reported implant removal in as many as 30 percent of patients who underwent immediate breast reconstruction with subsequent postmastectomy radiation therapy. 10 However, other studies with variations in the sequence of reconstruction stages have reported fewer failures with immediate implant reconstruction in the setting of postmastectomy radiation therapy. [11] [12] [13] This lack of agreement in the published literature warrants a longitudinal population-level examination of breast reconstruction outcomes for irradiated patients. Previous large database studies with a focus on reconstruction of the irradiated breast have suffered from an inability to follow patients longitudinally after they have undergone radiation and reconstruction; this was especially true for delayed breast reconstruction. 9 Use of a claims database in this current study uniquely allowed for the identification of patients who underwent mastectomy, radiation therapy, and reconstruction with detailed longitudinal follow-up. Thus, the aim of this study was to compare the morbidity associated with implant and autologous breast reconstruction techniques in a national sample of irradiated patients, with the goal of better defining the optimal approach to reconstruction in these patients.
PATIENTS AND METHODS

Data Source and Study Cohort
We 
Dependent Variables
One of the dependent variables was overall complications following the initial breast reconstruction procedure, including infection, wound complications, hematoma, mechanical implant complications (rupture), capsular contractures of implant, fat necrosis, and flap venous congestion. 14 The second dependent variable was reconstruction failure. (See Appendix, Supplemental Digital Content 1, below, which shows diagnosis and procedural codes for complications and reconstruction failure, http://links.lww.com/PRS/C86.) All complications captured had to be under a diagnosis of breast cancer to link them to the reconstruction procedure. To capture unsuccessful attempts at reconstruction that occurred during any stage of the reconstructive process, failures were defined as operations resulting in the termination of reconstruction, operations resulting in a repetition of an already performed stage of reconstruction, or a change in the reconstructive type at any point during the stipulated observation period. Failures were specifically defined as patients who underwent reoperation in one of the following scenarios: (1) patient had prosthesis procedure as the index procedure and then underwent removal of the tissue expander or implant without any further reconstruction procedures during the follow-up; (2) patient had prosthesis procedure as the index procedure and then had another tissue expander inserted during the follow-up; (3) patient had tissue expander inserted during the initial reconstruction and underwent exchange during follow-up, but received another or more than one exchange procedure following the first exchange; (4) patient had implant as the index procedure and received a replacement of the initial implant during the follow-up; (5) patient had a prosthesis procedure as the index procedure and then received implant plus flap or a flap alone; (6) patient had autologous tissue placed as the index procedure and then received another flap. Lastly, to count as reconstruction failures, the above six scenarios had to occur without a new procedure code for mastectomy, thus eliminating involvement of the contralateral breast as the reason for additional operations.
Independent Variables
Key independent variables included the index reconstruction type (prosthesis versus autologous tissue), timing of radiation therapy (before breast reconstruction versus after breast reconstruction), and timing of reconstruction (immediate versus delayed). Immediate reconstruction was defined as breast reconstruction procedures performed on the same day of mastectomy, and delayed reconstruction was defined as any reconstruction procedures performed after the mastectomy. Other variables included age, geographic region, median household income for metropolitan statistical area, comorbidities, and type of insurance plan. We linked the metropolitan statistical area identifier for each patient to the 2010 Census data and obtained median household income for their residence. Finally, we identified comorbid conditions using appropriate International Classification of Diseases, Ninth Revision, Clinical Modification codes, and these were classified using the Elixhauser method. 15, 16 We then included the Elixhauser comorbidity score as an independent variable.
Statistical Analysis
First, we described the distribution of the socioeconomic, demographic, and clinical variables in the study sample according to reconstruction type. Second, we described the distribution of complications of each reconstruction technique by timing of reconstruction and timing of radiation therapy. Third, we used the chi-square test to examine the unadjusted association between each complication and timing of reconstruction and radiation therapy. Lastly, we used a multivariable logistic regression model to examine associations between our previously outlined key independent variables and both dependent variables: (1) occurrence of any complications and (2) reconstruction failure.
RESULTS
We identified 4781 patients who met the inclusion criteria of breast reconstruction and radiation therapy for a breast cancer diagnosis. Eighty percent (n = 3846) underwent implant-based reconstruction and 20 percent (n = 935) underwent autologous reconstruction. Table 1 shows the social, demographic, and clinical characteristics of patients by reconstruction type (implant versus autologous tissue). Overall complication rates were 45.3 and 30.8 percent for patients with implant-based reconstruction and autologous reconstruction, respectively (Tables 2 and 3 ). In addition, failure of reconstruction occurred in 29.4 percent of patients with implant-based reconstruction compared with 4.3 percent for patients with autologous reconstruction. Figure 1 shows the comparison of individual complication and failure rates of patients who underwent implantbased and autologous reconstruction by the timing of reconstruction (immediate versus delayed) and timing of irradiation (before versus after reconstruction). The figure shows no consistent pattern of complication or failure rates by timing of reconstruction and irradiation in either group of patients; however, it shows a considerable difference in failure rates for irradiated patients who underwent implant-based compared with autologous reconstruction.
Adjusted estimates from logistic regression models (Table 4 and 5) show that patients who undergo implant-based reconstruction have two times the odds of having any of the complications examined compared with their counterparts who underwent autologous reconstruction. In addition, patients with implant-based reconstruction had 11 times the odds of reconstruction failure compared with their counterparts with autologous reconstruction. Lastly, the highest probability of reconstruction failure was among patients with implant-based delayed reconstruction and prereconstruction irradiation. The probability of failure for the average patient who had prereconstruction irradiation and delayed implant-based reconstruction was 37.2 percent. The lowest probability of failure was among patients with immediate autologous reconstruction with postreconstruction irradiation who had a failure probability of 3.5 percent. Figure 2 demonstrates the probability 
DISCUSSION
In this large national claims-based database study, we found, as has been shown in other studies, 9, 17, 18 that irradiated breast cancer patients predominantly underwent implant breast reconstruction. In addition, a majority (77 percent) of all irradiated patients underwent immediate reconstruction with subsequent irradiation. Over the 15-month follow-up period, overall postoperative complications were higher in patients with implant reconstruction compared with autologous reconstruction (45.3 percent versus 30.8 percent; p < 0.001). Complications were highest (51 percent) in patients who underwent postirradiation delayed implant breast reconstruction. Patients who underwent delayed autologous breast reconstruction had the lowest overall complication rate at 27 percent. Delayed implant breast reconstruction was also associated with the highest rate of reconstruction failure at 37 percent. Reconstruction failure in the setting of immediate implant reconstruction was significantly higher than failure observed in patients undergoing immediate autologous reconstruction (27.9 percent versus 3.7 percent; p < 0.001). The fact that breast or chest wall irradiation is associated with greater morbidity with postmastectomy breast reconstruction is generally accepted. However, there is far less agreement in the plastic surgery community on how best to reconstruct patients who require radiation therapy. Deciding on options for breast reconstruction should require consideration of patient preferences, anatomical constraints, and safety in terms of reasonably successful outcomes of reconstruction with avoidance of adverse effects to the patient. This study particularly addresses the issue of safety.
With the growing popularity of implant-based breast reconstruction in irradiated patients, the literature is replete with multiple single-center retrospective studies conducted to assess postoperative outcomes with this reconstructive approach. In that series, the overall complication rate in irradiated breasts was 40.7 percent, and specific complications necessitating implant removal or replacement occurred in 18.5 percent of the irradiated breasts. Lastly, irradiated patients reconstructed with implants at the Memorial Sloan Kettering Cancer Center, when compared to similar nonirradiated patients, reported significantly lower quality of life and satisfaction with their reconstructed breasts. 20 With some variability of reported complications in the existing literature, 10 findings on complications in this current study with a 45.3 percent implant complication rate and a 29.4 percent failure rate agree with the published literature. These complication rates in our study translated to two and 11 times greater odds of complications and failures of reconstruction, respectively, with implant-based reconstruction in irradiated patients compared with autologous reconstruction (Tables 4 and 5) .
Existing literature also provides robust evidence that autologous flap alternatives are associated with better success rates and high levels of patient satisfaction. 21, 22 A systematic review of the published literature on autologous reconstruction outcomes in the face of irradiation revealed relatively low pooled flap failure rates with reconstruction performed before (4 percent) or after delivery of radiation therapy (1 percent). 23 Given that the results of our study are based on a broader nationwide sample of patients and institutions and are in general agreement with existing studies, we suggest the following implications: implantonly reconstruction in the irradiated patient should be an exception and not the rule. From the standpoint of safety (i.e., reasonably successful outcomes of reconstruction with avoidance of adverse effects to the patient), our study findings with flap failures ranging from 3 to 5 percent support the notion that autologous tissue reconstruction has a lower risk for complications and failure for irradiated patients.
The primary concerns with autologous reconstruction in irradiated patients have to do with the timing of reconstruction relative to radiation exposure. Specifically, these concerns center on exposure of flaps to radiation (i.e., immediate reconstruction with subsequent postmastectomy radiation therapy). Multiple studies have reported fat necrosis, flap volume loss, and contraction as reasons to avoid flap exposure to radiation therapy, 4, 6, 24 favoring delaying reconstruction for a period after irradiation. However, the tradeoffs of delaying reconstruction include patients having to live without a breast for extended periods, intraoperative challenges working with irradiated recipient vessels, and more prominent scars with the delayed flap inset. Kronowitz et al.
championed the delayed-immediate method to mitigate the soft-tissue deficit issues of delayed reconstructions. 24 Tissue expanders are placed at the time of mastectomy, allowing for expansion and preservation of the soft-tissue envelope even after exposure to radiation. This modification also has its problems with complications, requiring expander removal in approximately one-third of cases. 25 Finally, existing data on the clinically significant effects of radiation on autologous flaps are mixed. The recent evaluation by Mirzabeigi et al. of 127 abdominally based free flap reconstructions exposed to radiation did find a higher incidence of volume loss and fat necrosis compared with similar nonirradiated reconstructions. 26 However, the irradiated patients did not experience a higher rate of complications and required an equivalent number of revision procedures as nonirradiated patients to achieve a complete reconstruction. 24 In contrast, volumetric assessments performed by Chatterjee and colleagues on flaps exposed to radiation therapy demonstrated a volume decrease in the irradiated flaps that was not significantly different from similar nonirradiated flaps. 27 The variation in reports on the effect of radiation on flaps likely has to do with the unavoidable differences in irradiation protocols from institution to institution. In addition, most studies on this topic provide relatively short-term followup data, with radiation changes expected to occur over many years. Nevertheless, it appears that the incidences of clinically significant volumetric loss and fat necrosis are somewhat ambiguous and not clearly defined. Furthermore, these changes may not affect the ultimate outcome of an autologous breast reconstruction exposed to radiation, especially when anticipated and adjusted for with initial flap oversizing.
This study has limitations. Although the MarketScan database represents a large population, it lacks information on race/ethnicity and only includes commercially insured patients, typically of working age, limiting its generalizability. Reconstruction type may be influenced by nonclinical factors including surgeon preference, patient preference, or financial implications for reimbursement that cannot be accounted for in the database. Lastly, other pertinent clinical factors such as body mass index, race, smoking history, prior operations that may preclude autologous reconstruction, or preference of reconstruction method by the patient or the surgeon are not provided in the database. Despite these limitations, we present data that provide some insight into the morbidity associated with varying approaches to breast reconstruction in patients undergoing radiation therapy.
CONCLUSIONS
Implant-based breast reconstruction in patients exposed to radiation therapy, although popular, is associated with significant morbidity. Failures of reconstruction with this method approach 30 percent in the short term. Appreciating the importance of patient preferences, there is still a need for careful shared decision-making with full disclosure of the potential morbidity associated with implant-only reconstruction in irradiated patients. Also, given that autologous reconstruction of the irradiated breast results in significantly fewer complications and failures, it is critical that reconstructive surgeons reassess their approach to surgical management in this growing patient population.
